Page last updated: 2024-08-25

4-aminoquinazoline and Invasiveness, Neoplasm

4-aminoquinazoline has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ding, H; Liu, Y; Lu, H; Qin, X; Ren, T; Wang, S; Wu, Q; Zhang, Y; Zhao, Q	1

Other Studies

1 other study(ies) available for 4-aminoquinazoline and Invasiveness, Neoplasm

Article	Year
A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway. Cell death & disease, 2020, 06-30, Volume: 11, Issue:6 Topics: Animals; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice, Nude; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2020

Article

Year

A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.

Cell death & disease, 2020, 06-30, Volume: 11, Issue:6

Topics: Animals; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice, Nude; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2020